Published in Blood Weekly, April 14th, 1997
Both Oncogene Science and Hoechst Marion Roussel contribute medicinal chemistry and preclinical optimization teams and Hoechst Marion Roussel are responsible for the clinical development of drug candidates emerging from the program.
The program focuses on the preclinical and clinical development of lead...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.